Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD)

Clinical trial NCT07086521 · RECRUITING

Trial details

NCT number: NCT07086521
Sponsor: Restem, LLC.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

FSHD - Facioscapulohumeral Muscular Dystrophy

Start date: 2025-12-01
Primary completion: 2028-09-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.